Lumbar Radiculopathy (Sciatica)
Investigational use for lumbar radiculopathy; the closest randomized evidence is in chronic low back pain (Hohmann 2018, n=44), not radicular pain.
Patient Summary
- Is this FDA-cleared for this use?
- No — investigated off-label. The FDA cleared medicinal leeches in 2004 only for venous congestion in microsurgical reconstruction (K040187). Use for lumbar radiculopathy is investigational and not FDA-evaluated; the one published randomized trial was in chronic low back pain, not sciatica.
- What evidence exists?
- The closest randomized evidence is Hohmann 2018 (chronic low back pain, n=44): leech therapy, compared with four weekly exercise sessions, reduced back-pain intensity at 28 days. That trial enrolled patients with chronic nonspecific low back pain, not patients selected for radicular (leg) pain, so it does not establish benefit for lumbar radiculopathy. Older Russian series summarized in a 2004 monograph report benefit in sciatica and vertebrogenic radiculopathy, but they were not randomized and their primary reports could not be retrieved. Leech therapy is not a substitute for surgical evaluation in patients with progressive weakness, foot drop, or cauda equina syndrome (loss of bladder or bowel control), which are surgical emergencies. Standard treatments — physical therapy, NSAIDs, and epidural steroid injection — remain first-line.
- Main risks
- Bleeding and oozing from each bite site for hours to a full day (using multiple leeches means cumulative blood loss can be significant)
- Mild anemia from cumulative blood loss with higher leech counts
- Bruising and tenderness along the low back, buttock, and leg for 3 to 7 days
- Itching, redness, and irritation at bite sites for days to weeks
- Local skin infection or, rarely, Aeromonas infection from leech gut bacteria
- Allergic reaction to leech saliva (uncommon)
- Temporary worsening of pain or stiffness for 1 to 2 days after the session
- Small bite marks that usually fade over weeks to months (rarely a pale spot stays longer)
- Who should not consider this
- Patients taking blood thinners such as warfarin, apixaban, rivaroxaban, dabigatran, or heparin
- Patients with hemophilia or other inherited bleeding disorders
- Patients with anemia
- Patients with a weakened immune system
- Patients with cauda equina syndrome — loss of bladder or bowel control, saddle numbness (surgical emergency, go to the ER)
- Patients with progressive leg weakness or foot drop (urgent surgical evaluation)
- Patients with any sign of spinal infection (fever, IV drug use history, recent spinal procedure)
- What to ask your clinician
- Have I had an MRI, and is there a structural problem that needs surgical evaluation first?
- Have I given physical therapy, NSAIDs, and epidural steroid injection a fair trial?
- Am I a candidate for surgery now, and would that be a better option for me?
- What is the practitioner's experience treating sciatica with leeches specifically?
- How will my blood count be monitored, especially given that multiple leeches will be used?
- What antibiotic plan do you use for Aeromonas prevention?
- What red flags require me to go to the ER immediately?
- What is the cost, and is it covered by insurance? (typically not)
- When to seek urgent care
- Loss of bladder or bowel control, numbness in the groin or inner thighs (cauda equina syndrome — go to the ER immediately)
- New or worsening weakness in the leg or foot drop
- Sudden severe back pain with fever (possible spinal infection)
- Bleeding from a bite site lasting more than 24 to 48 hours, or soaking through dressings
- Spreading redness, warmth, pus, or red streaks (cellulitis)
- Fever above 38.0 C / 100.4 F or chills
- Hives, throat tightness, or breathing difficulty
What this does NOT mean
- It does not mean leech therapy is FDA-cleared for sciatica — it is not.
- It does not mean leech therapy fixes the underlying disc problem — it may temporarily reduce symptoms only.
- It does not mean it replaces surgical evaluation for red-flag features (progressive weakness, foot drop, cauda equina).
- It does not mean every patient benefits — the closest published trial was in chronic low back pain, not radiculopathy, and results vary widely.
- It does not mean improvement is permanent — in the closest trial, follow-up extended only to 8 weeks.
Safety cross-references
Clinical Profile
- Category
- Neurological
- ICD-10
- M51.16, M51.17, M54.30, M54.31, M54.32, M54.40, M54.41, M54.42
- Safety tier
- Medium
Evidence Summary
No randomized trial of leech therapy specifically for lumbar radiculopathy or sciatica was identified in PubMed, Europe PMC or Crossref. Russian clinical series summarized in the Baskova and Isakhanyan 2004 monograph report benefit in sciatic neuritis or neuralgia (Kasimov, 50 patients, no control group described) and in vertebrogenic radiculopathy (Arutyunov 1998, 37 patients, leeches with manual therapy versus a control group without leeches; Konyrtaeva and Tulesarinov 1999, 280 patients); their primary reports could not be retrieved. A single-patient report (Nouri 2012) describes temporary relief of L5 radiculopathy before discectomy. The closest randomized evidence is a 2018 randomized controlled trial in chronic low back pain (not radiculopathy), which randomized 44 patients to leech therapy (n=25) versus four weekly sessions of exercise therapy (n=19). Mean back-pain VAS improved from 61.2 to 33.1 with leech therapy versus 61.6 to 59.8 with exercise at day 28 (group difference -25.2; 95% CI -41.0 to -9.45; p=0.0018), with physical function and quality of life also favoring leech therapy at 4 and 8 weeks; the trial was unblinded and small. Extension to radicular leg pain is unproven, and use for radiculopathy is investigational. Leech therapy is not a substitute for surgical evaluation in patients with progressive motor deficit or cauda equina syndrome.
What the books describe
Below is a summary of what books on hirudotherapy say about this condition. These are the authors’ observations, not a proven effect and not a promise of results. Hirudotherapy has contraindications; the decision is made by a physician.
- Baskova and Isakhanyan do not write separately about lumbar radiculopathy specifically: they describe vertebrogenic (spine-related) radiculopathies in general, name herniations and bulges of the intervertebral disc as the most common cause of pain, include these radiculopathies in their list of diseases for which leech treatment is recommended, and conclude that hirudotherapy “is indicated and widely used” for them[B1].
- They retell the report by Arutyunov and co-authors (1998) on 37 patients with chronic, often exacerbating vertebrogenic radiculopathy in whom MRI found disc extrusions and multiple herniations: the patients were treated with leeches combined with manual therapy, and, according to the authors, remission in 30 patients of the main group lasted 1–3 years, and in the control group without leeches 6–8 months; how the 37 patients were divided into groups is not clear from the text[B1].
- Another report they retell (Konyrtaeva and Tulesarinov, 1999) concerns 280 patients with vertebral disease whose diagnosis was made from images showing a herniated or bulging disc; according to the authors, most patients had a positive clinical effect; how it was assessed, whether there was a control group and how long the patients were followed is not stated in the retelling[B1].
- Michalsen et al. call hirudotherapy an excellent alternative for vertebrogenic pain syndromes, especially when the physical examination reveals painful hardening of muscles and connective tissue next to the spine, and, for lumboischialgia and chronic pain due to lumbar disc herniation, a useful adjunct to physical therapy and pain management; in these cases, in their words, the potent anti-inflammatory effect of leech saliva can be very beneficial[B3].
- In the chapter on the scientific basis of the method, Michalsen acknowledges that low back pain and sacroiliac joint pain are commonly and successfully (by subjective assessment) treated with leeches, but data from clinical trials on this are lacking[B3].
- Neither Baskova and Isakhanyan nor Michalsen et al. discuss which manifestations of radicular (nerve-root) pain require emergency care, so this question cannot be settled from these books; Michalsen et al. only write that for pain in the lower back (lumbago), a disc herniation and other primary causes must be excluded before treatment starts[B3].
- Both books list hemophilia, anemia and concurrent use of anticoagulants among the contraindications (this is only part of their lists); Flecken and Michalsen add that aspirin or clopidogrel are not in themselves considered a contraindication, but in that case the number of leeches is reduced at the first session[B1][B3].
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)
Key Trials
- Hohmann CD et al. (2018), n=44 · Dtsch Arztebl Int · PMID 30636672 · ASH analysis →
Contraindications
- Hemophilia or another bleeding disorder
- Taking anticoagulants (blood thinners such as warfarin or heparin)
- Anemia or suppressed blood formation
- Low blood pressure, shock, collapse or fainting
- Severe wasting (cachexia)
- Intolerance of leeches or a history of severe allergic reactions
- Pregnancy
- Stomach or duodenal ulcer, erosive gastritis
- Acute infectious disease or high fever
- Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
- Drinking alcohol at the time of treatment
- No consent from the patient
- Cauda equina syndrome (surgical emergency)
- Progressive motor deficit
- Spinal infection
Related Conditions
Cervical Radiculopathy
Investigational use for cervical radiculopathy; no verifiable published trial specific to this indication.
Sciatica (Non-Discogenic / Piriformis)
Investigational use for non-discogenic sciatica including piriformis syndrome; no controlled trial, only an old unquantified Russian case series.
Chronic Low Back Pain (nonspecific)
One small, unblinded randomized trial (Hohmann 2018, n=44): back pain was lower 4 weeks after leech therapy than after exercise therapy; follow-up 8 weeks.
Migraine
Investigational use; the only clinical studies found in journal searches are a 7-patient case series and a 26-patient non-randomized pilot (older reports are described in “What the books describe”), and the proposed mechanism is hypothetical.
References
- [B1]
Баскова И.П., Исаханян Г.С. Гирудотерапия. Наука и практика [Hirudotherapy: Science and Practice]
Monograph in Russian, 506 pp., ISBN 5-89527-058-1. Chapter 15: sensation at the bite, length of the session; secretion kininases and pain.
- [B3]
Michalsen A., Roth M., Dobos G. Medicinal Leech Therapy
ISBN 978-3-13-143581-1 / 978-1-58890-563-5. Chapter 9, p. 107: perceptions of the bite — a local dragging pain lasting around one to five minutes.
The information on this page is based on the hirudotherapy books listed under References and reflects the experience their authors describe. Sensations and results differ from person to person. This information is not medical advice, a diagnosis or a prescription, and it does not replace an examination by a physician. Do not stop or change any prescribed treatment without your physician. Hirudotherapy has contraindications.